Platelet-neutrophil interactions during hemodialysis: A proposed biocompatibility approach

International Journal of Artificial Organs

Volumn 21, Issue 2, 1998, Pages 75-82

  Stuard, S ^a   Bonomini, M ^a,b   Settefrati, N ^a   Albertazzi, A ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

Author keywords

Biocompatibility; Flow cytometry; Hemodialysis membranes; Hydrogen peroxide; Modified cellulose; Platelet neutrophil aggregation

Indexed keywords

CELLS; CELLULOSE; CYTOLOGY; DIALYSIS; FLOW CYTOMETRY; HEMODIALYZERS; HYDROGEN PEROXIDE; OXIDATION; PLATELETS; ULTRAFILTRATION;

CELLULOSE DIACETATES; CUPROPHAN; HAEMODIALYSIS; HAEMODIALYSIS MEMBRANES; MODIFIED CELLULOSE; NEUTROPHIL INTERACTION; P-SELECTIN; PLATELET-NEUTROPHILE AGGREGATION; REACTIVE OXYGEN SPECIES; SYNTHETIC MEMBRANES;

BIOCOMPATIBILITY;

CELLULOSE; CUPROPHANE; HEMODIALYSIS FLUID; HYDROGEN PEROXIDE; POLY(METHYL METHACRYLATE); POLYACRYLONITRILE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; ARTIFICIAL MEMBRANE; BIOCOMPATIBILITY; CELL INTERACTION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; MALE; MATERIALS TESTING; NEUTROPHIL; THROMBOCYTE AGGREGATION;

EID: 0031898399     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bonomini V. Introducing the biology of bioincompatibility in dialysis. Nephrol Dial Transplant 1991; 6 (Suppl. 2) 1-3.
2. Craddock PR, Fehr J, Brigham KL, Kroneberg RS, Jacob HS. Complement and leukocyte mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977; 296: 769-74.
3. Craddock PR, Hammersmith DE, White JG, Dalmasso AP, Jacob HS. Complement (C5a) induced granulocyte aggregation in vitro: A possible mechanism of complement mediated leukostasis and leukopenia. J Clin Invest 1977; 60: 260-4.
4. Hakim RM, Fearon DT, Lazarus JM. Biocompatibility of dialysis membranes: Effects of chronic complement activation. Kidney Int 1984; 26: 194-200.
5. Gawaz MP, Mujais SK, Schmidt B, Gurland HJ. Plateletleukocyte aggregation during hemodialysis. Kidney Int 1994; 46: 489-95.
6. Stuard S, Carreno MP, Poignet JL, Albertazzi A, Haeffner-Cavaillon N. A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis. Kidney Int 1995; 48: 93-102.
7. Carreno MP, Stuard S, Bonomini M, et al. Cell-associated adhesion molecules as early markers of bioincompatibility. Nephrol Dial Transplant 1996; 11: 2248-57.
8. Ware JA, Heistad DD. Platelet endothelium interactions. N Engl J Med 1993; 328: 628-35.
9. Bonomini M, Stuard S, Carreno MP, et al. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin. Nephron 1997; 75: 402-11.
10. Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM. Intradialytic granulocyte reactive oxygen species production: A prospective, crossover trial. J Am Soc Nephrol 1993; 4: 178-86.
11. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Baintor DF. A platelet alpha granule membrane protein (GMP140) is expressed on the plasma membrane after activation. Cell Biol 1985; 101: 880-5.
12. Rinder HM, Bonan JL, Rinder CS, Jacques YV, Baintor DF. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991; 78: 1760-9.
13. Rosenkranz AR, Tempi E, Traindl O, Heinzl H, Zlabinger GJ. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membrane. Clin Exp Immunol 1994; 98: 300-5.
14. Hymmelfarb J, Hakim RM, Holbrook DG, Leeber DA, Ault KA. Detection of granulocyte reactive oxygen species production in whole blood using flow cytometry. Cytometry 1992; 13: 83-9.
15. Henderson LW, Cheung AK, Chenoweth DE. Choosing a membrane. Am J Kidney Dis 1983; 3: 5-20.
16. Bergstrom J. Hemodialysis. Does the membrane matter? Semin Dial 1989; 2: 7-10.
17. Klinkmann H, Vienken J. Membranes for dialysis. Nephrol Dial Transplant 1995; 10 (Suppl. 3): 39-45.
18. Bosch T, Schmidt B, Samtieben W, Gurland H. Biocompatibility and clinical performance of a new modified cellulosic membrane. Clin Nephrol 1986; 26 (Suppl): 22-29.
19. Falkenhagen D, Bosch T, Brown G, et al. A clinical study on different cellulosic membranes. Nephrol Dial Transplant 1987; 2: 537-45.
20. Ivanovich P, Chenowelth D, Schmidt R, et al. Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int 1983; 24: 758-63.
21. Schafer R, Huber L, Gilge U, Bausewein K, Vienken J, Heidland A. Clinical evaluation of a new high-flux cellulose acetate membrane. Int J Artif Organs 1989; 12: 85-90.
22. Woffindin C, Hoenich NA, Matthews JNS. Cellulose-based hemodialysis membranes. Biocompatibility and functional performance compared. Nephrol Dial Transplant 1992; 7: 340-5.
23. Bonomini V, Coli L, Feliciangeli G, Mosconi G, Scolari MP. Long-term results: cellulosic vs synthetic membranes. Contrib Nephrol 1995; 113: 120-34.
24. Chenowelth DE. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications. Artif Organs 1984; 8: 281-7.
25. Cheung AK, Parker CJ, Wilcox LA. Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan. Kidney Int 1990; 37: 1055-9.
26. Ward RA, Schafer RM, Falkenhagen D, et al. Biocompatibility of a new high-permeability modified cellulose membrane for hemodialysis. Nephrol Dial Transplant 1993; 8: 47-53.
27. Faint RW. Platelet-neutrophil interactions. Their significance. Blood Rev 1992; 6: 83-91.
28. Bazzoni G, Dejana E, Del Maschio A. Platelet neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 1991; 76: 491-499.
29. Nagata K, Tsuji T, Todoroki N, et al. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin. J Immunol 1993; 151: 3267-73.
30. Carulli G, Barsotti G, Cupisti A, et al. Platelet-neutrophil interactions in uremic patients: effects on neutrophil superoxide anion production and chemiluminescnece. Nephron 1995; 69: 248-52.
31. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J 1991; 10: 2247-58.
32. Cappelliere-Blandin C, Delaveau T, Descamps-Latscha B. Structural modifications of human beta 2-microglobulin treated with oxygen-derived radicals. Biochem J 1991; 277: 175-82.
33. Weiss SJ, Young J, LoBuglio AF, Slivka A, Nimer NF. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest 1981; 68: 714-21.
34. Martin WJ. Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis 1984; 130: 209-13.
35. Malech HL, Gallin JI. Neutrophils in human diseases. N Engl J Med 1987; 317: 687-94.
36. Yagi K. A biochemical approach to atherogenesis. Trends Biochem Sci 1986; 11: 18-19.
37. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.
38. Richard MJ, Arnaud J, Jurkovitz C, et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991; 57: 10-15.
39. Schulman G, Fago A, Gung A, Baor K, Hakim R. Complement activation retards resolution of ischemic renal failure in the rat. Kidney Int 1991; 40: 1069-74.